Literature DB >> 10080385

Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases.

E J Mufson1, J S Kroin, T J Sendera, T Sobreviela.   

Abstract

Neurotrophins play a crucial role in the maintenance, survival and selective vulnerability of various neuronal populations within the normal and diseased brain. Several families of growth promoting substances have been identified within the central nervous system (CNS) including the superfamily of nerve growth factor related neurotrophin factors, glial derived neurotrophic factor (GDNF) and ciliary neurotrophic factor (CNTF). In addition, other non-neuronal growth factors such as fibroblast growth factor (FGF) have also been identified. This article reviews the trophic anatomy of these factors within the CNS. Intraventricular and intraparenchymal injections of exogenous nerve growth factor result in retrograde labeling mainly within the cholinergic basal forebrain. Distribution of brain derived neurotrophic factor (BDNF) following intraventricular injection is minimal due to the binding to the trkB receptor along the ventricular wall. In contrast, intraparenchymal injections of BDNF results in widespread retrograde transport throughout the CNS. BDNF has also been shown to be transported anterogradely within the CNS. Infusion of GDNF into the CNS results in retrograde transport limited to the nigrostriatal pathway. Hippocampal injections of NT-3 retrogradely label mainly basal forebrain neurons. Retrograde transport of radiolabeled CNTF has only been observed in sensory neurons of the sciatic nerve. Following intraventricular and intraparenchymal infusion of radiolabeled bFGF, retrograde neuronal labeling was found in the telecephalon, diencephalon, mesencephalon and pons. In contrast retrograde labeling for aFGF was found only in the hypothalamus and midbrain. Since select neurotrophins traffic anterogradely and retrogradely within the nervous system, these proteins could be used to treat neurological diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10080385     DOI: 10.1016/s0301-0082(98)00059-8

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  40 in total

1.  Fibroblast growth factor-2 promotes axon branching of cortical neurons by influencing morphology and behavior of the primary growth cone.

Authors:  G Szebenyi; E W Dent; J L Callaway; C Seys; H Lueth; K Kalil
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 2.  Anterograde transport of neurotrophic factors: possible therapeutic implications.

Authors:  Matteo Caleo; Maria Cristina Cenni
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

Review 3.  On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease.

Authors:  Simona Capsoni; Antonino Cattaneo
Journal:  Cell Mol Neurobiol       Date:  2006-08-31       Impact factor: 5.046

4.  Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia.

Authors:  Chie Yasutake; Kenji Kuroda; Toshio Yanagawa; Takehiko Okamura; Hiroshi Yoneda
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

5.  Leverpress escape/avoidance training increases neurotrophin levels in rat brain.

Authors:  David S Albeck; Kevin D Beck; Ling-Hsuan Kung; Kazuhiro Sano; Francis X Brennan
Journal:  Integr Physiol Behav Sci       Date:  2005 Jan-Mar

6.  Neurotrophic factors rescue basal forebrain cholinergic neurons and improve performance on a spatial learning test.

Authors:  Yu-Shang Lee; Andalib Danandeh; Janie Baratta; Ching-Yi Lin; Jen Yu; Richard T Robertson
Journal:  Exp Neurol       Date:  2013-09-07       Impact factor: 5.330

Review 7.  Neuroprotective strategies in Alzheimer's disease.

Authors:  Frank M Longo; Stephen M Massa
Journal:  NeuroRx       Date:  2004-01

8.  The locus ceruleus responds to signaling molecules obtained from the CSF by transfer through tanycytes.

Authors:  Cheng-Yuan Feng; Larisa M Wiggins; Christopher S von Bartheld
Journal:  J Neurosci       Date:  2011-06-22       Impact factor: 6.167

9.  Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.

Authors:  Sylvia E Perez; Bin He; Muhammad Nadeem; Joanne Wuu; Stephen W Scheff; Eric E Abrahamson; Milos D Ikonomovic; Elliott J Mufson
Journal:  Biol Psychiatry       Date:  2014-01-11       Impact factor: 13.382

10.  Calcium signals and FGF-2 induced neurite growth in cultured parasympathetic neurons: spatial localization and mechanisms of activation.

Authors:  P Zamburlin; F A Ruffinatti; A Gilardino; S Farcito; M Parrini; Davide Lovisolo
Journal:  Pflugers Arch       Date:  2013-03-26       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.